Short-Interval Botulinum Toxin Chemodenervation in Patients With Neurologic Voice Disorders

This cohort study aims to determine the proportion and characteristics of patients who receive botulinum toxin chemodenervation treatment in intervals shorter than 90 days.
Source: JAMA Otolaryngology - Head and Neck Surgery - Category: ENT & OMF Source Type: research